Dow Down0.17% Nasdaq Down0.28%

Salix Pharmaceuticals Ltd. (SLXP)

-NasdaqGS
156.24 0.46(0.30%) Sep 30, 4:15PM EDT
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.1
Mean Recommendation (last week):1.9
Change:0.2

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:166.35
Median Target:177.00
High Target:195.00
Low Target:125.00
No. of Brokers:17

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Jun 27, 2014Canaccord GenuityInitiated Buy
Mar 18, 2014National Alliance SecuritiesInitiated Buy
Dec 17, 2013StifelUpgradeHoldBuy
Aug 5, 2013Cantor FitzgeraldDowngradeBuyHold
Jan 11, 2013RBC Capital MktsInitiated Outperform
Nov 30, 2012MizuhoInitiated Buy
Aug 9, 2012Cantor FitzgeraldUpgradeHoldBuy
Jul 30, 2012Cantor FitzgeraldDowngradeBuyHold
Apr 10, 2012AurigaDowngradeBuyHold
Feb 28, 2012AurigaUpgradeHoldBuy

More Upgrades & Downgrades for SLXP

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy6666
Buy6656
Hold5555
Underperform1000
Sell0000

Data provided by Thomson/First Call


Currency in USD.